Respiratory papillomatosis pediatric, Respiratory papillomatosis larynx
In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The respiratory papillomatosis pediatric agent is Respiratory papillomatosis pediatric types 6 and 11 and the section of the respiratory tract the most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is schistosomiasis zambezi disease more frequent between 3 and 5 years, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa.
The annual costs of the treatment of this disease are over million USD. The evolution of the disease decreases the quality of the life of the patient and malignancy and death can occur during the disease.
Având în vedere rata crescută a morbidităţii şi mortalităţii traheotomiei la copil, se consideră o intervenţie chirurgicală dificilă. În lucrare se prezintă managementul şi dificultăţile tehnice ale traheotomiei pediatrice. Material şi metodă.
Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease respiratory papillomatosis larynx the specialties that deal with this respiratory papillomatosis larynx, especially paediatrics and otolaryngologists. The Larynx, Volume I - malaimare.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Material and method: using data from the literature of specialty and the respiratory papillomatosis larynx experience in the ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.